Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system
Oncotarget
.
2018 Jul 27;9(58):31167-31168.
doi: 10.18632/oncotarget.25795.
Authors
Fabio Conforti
1
,
Laura Pala
1
,
Aron Goldhirsch
1
Affiliation
1
Division of Medical Oncology for Melanoma & Sarcoma, European Institute of Oncology, Milan, Italy.
PMID:
30131843
PMCID:
PMC6101279
DOI:
10.18632/oncotarget.25795
No abstract available
Keywords:
Immune checkpoint inhibitos; immune system; immunotherapy; sex hormones; sex-dimorphism.
Publication types
Editorial